OBORDA / AVIATION INFRASTRUCTURE
Leidos is a government technology and engineering company spanning defense, civil agencies and health. In air traffic management, it provides systems including ERAM and Terminal Flight Data Manager.
Observe: what is confirmed?
Leidos has established automation products inside the FAA. That is relevant to both continued deployments and future automation competitions, but does not guarantee selection for a replacement Common Automation Platform.
Sources: Leidos: FAA automation systemsEarnings and valuation
Q3 revenue was $4.63 billion and adjusted EPS $3.62. FY2026 adjusted EPS guidance is $12.50–$12.70; I use $12.60. Revenue guidance of $18.0–$18.2 billion reflects a portfolio transaction, so a lower revenue range should not be read without that context.
Sources: Leidos: Q3 2026 resultsPrice structure
At $130.53, the drawdown from the $205.00 52-week high is 36.33%. The dated November 13 indicator snapshot places the 50-day average at $128.78 and the 200-day at $138.39. Price is near the former and below the latter: recovery remains unconfirmed.
Sources: LDOS dated price history and indicatorsOrient: how the FAA story fits
Among these U.S. names, Leidos offers an interesting combination of existing FAA relevance and a low earnings multiple in this snapshot. The opportunity remains broader than one funding headline; execution and contract retention must support the discount.
Timing: Existing tower software deployment: underway through 2028. Additional automation procurement: 2027–2029 analytical window. Large replacement-platform deployment could run into the 2030s; no official phase-two completion date is established.
Business-to-stock bridge: Funding must become an obligation, an awarded scope of work, profitable delivery and ultimately cash flow. I have not assigned this company an invented share of the proposed $50 billion.
Decide: six valuation zones
Anchor: $12.60 annual EPS; snapshot multiple: 10.36×. Boundaries equal EPS × the stated multiple. These are provisional valuation bands, not verified chart support. Multiples are my risk allowances, not peer-consensus targets. They deliberately exclude an assumed incremental FAA earnings contribution.
| Zone | Price | Boundary rationale |
|---|---|---|
| Reassess | Below $100.80 | Below 8× EPS: the price may signal a broken assumption; stop and re-underwrite. |
| High conviction — conditional | $100.80 to below $113.40 | 8–9×: deepest valuation allowance, conditional on intact earnings and contracts. |
| Accumulation — conditional | $113.40 to below $126.00 | 9–10×: larger margin of safety; stagger entries. |
| Starter — conditional | $126.00 to below $151.20 | 10–12×: smaller initial position; no presumed FAA windfall. |
| Watch / no new money | $151.20 to below $189.00 | 12–15×: insufficient discount under this model. |
| Trim review | $189.00 and above | At least 15×: review concentration and valuation; no automatic sale. |
The lowest bands permit more valuation risk only while business quality remains intact. A falling price after adverse contract news is a reason to reassess, even inside a buy band. These stocks share federal-spending exposure, so buying several is not full diversification.

12–24 month valuation scenarios
Bear: EPS falls 15% and valuation contracts to the lowest modeled multiple. Base: EPS holds and trades at the midpoint of the starter multiples. Bull: EPS grows 10% and trades at the trim-review multiple. These are conditional sensitivities, not probability-weighted expected returns. Price returns exclude dividends, taxes and fees.
| Case | EPS assumption | P/E | Implied price | Return vs reference |
|---|---|---|---|---|
| Bear | $10.71 | 8× | $85.68 | -34.4% |
| Base | $12.60 | 11× | $138.60 | +6.2% |
| Bull | $13.86 | 15× | $207.90 | +59.3% |
Risks and invalidation
Legacy systems can be replaced by competitors, federal awards can slip, and the low multiple may reflect business risks unrelated to the FAA. Contract ceilings do not ensure profitable revenue.
Thesis breaks if: Loss of key FAA automation scope, a sustained earnings-guidance cut or weakening cash conversion would defeat the discount thesis.
Confidence: High on existing product relevance; medium on the valuation case; low on the winner and schedule of future platform awards.
Act: my next move
Conditional starter candidate at $130.53, about 10.36 times my EPS anchor. Use a small initial allocation only if the broader business thesis is intact; retain cash for lower bands and verify the executable quote.
Next evidence to check: funded task orders, award modifications, company backlog commentary, margins and cash collections. Price bands are review points, not standing orders. Staggered purchases. No all-ins.
Market context and limits
Federal procurement can proceed while the wider market falls. Higher discount rates would reduce the multiples I am willing to pay. I assign no seasonal November/December return advantage: the catalysts here are appropriations, awards and results. Current options positioning, institutional flows and a fully reconciled adjusted OHLC history were not verified; no flow claim or automated technical signal is used. The missing data limits confidence in entry timing. Refresh prices, corporate actions and earnings guidance before acting.
OODA: Observe the funded scope → Orient it against the whole company → Decide whether valuation compensates for risk → Act only when both evidence and price qualify.

